RedMedEd

From new immunotherapies to AE management, this game-based CME activity from tests your bladder cancer care acumen while presenting essential information to help keep your practice current and your patients thriving. @RedMedEd

🙌

Med oncs, urologists, APPs, onc nurses: if you see bladder cancer (BC) patients, don’t miss this CME Clinical Callout activity with @RedMedEd

Keep pace with relapsed/refractory myeloma care and earn on-the-go CME with @theMMRF and @HJChoMDPhD1. Designed with a slick, streamlined interface optimized for mobile devices, this activity covers a number of key topics. Earn your credit today: tinyurl.com/RRMMRMEx #mmsm

With @BladderCancerUS and @ERPlimackMD our CME-accredited Clinical Callout activity puts your bladder cancer (BC) care acumen to the test while reviewing the latest developments in BC management. Don’t miss out: tinyurl.com/BCCCRME

Expiring soon: CME on bladder cancer guidelines and emerging immunotherapies. To learn more, visit tinyurl.com/CEminRME Don’t delay: this activity expires on February 21 @ERPlimackMD @BladderCancerUS

Wow!!! #ASH2025

Ready, set… hunt! 👀 Join the first-ever #ASHScavengerHunt at #ASH25! Explore, snap, and share your experience at the 2025 ASH Annual Meeting and Exposition. Register now: bit.ly/3K7pgo3

Looking for CME with challenging bladder cancer cases? Try our online, interactive Clinical Callout on emerging options for bladder cancer care: tinyurl.com/BCCCRME with @ERPlimackMD and @BladderCancerUS

Our online mobile-friendly CME activity on advances in RRMM management tinyurl.com/RRMMRMEx, includes downloadable tools that are sure to be invaluable to your practice. @theMMRF; @HJChoMDPhD1 #mmsm

Bladder cancer care professional development for APPs—game show style with @BladderCancerUS and Colleen Tetzlaff @Onc_PA_Mom! Don’t just sit in the studio audience: play a round today! tinyurl.com/BCSBFRME

Good news for myeloma patients #mmsm gsk.com/en-gb/media/pr…

Such a huge loss for the myeloma community. Condolences to Dr. Durie's family and friends.

Is your knowledge of bladder cancer care up to date?Our CME-accredited Q-Challenge activity tests your knowledge of—and provides insights on—the latest advances: tinyurl.com/RMDQchl @BladderCancerUS

Designed with a slick, streamlined interface optimized for mobile devices, our newest interactive CME activity on recent advances in RRMM management is now available! @theMMRF #mmsm Start here ➡️tinyurl.com/RRMMRMEx

From No Hope to a Potential Cure for a Deadly Blood Cancer @ginakolata #mmsm #ciltacel nytimes.com/2025/06/03/hea…

The @US_FDA ODAC recommends approval of daratumumab (Darzalex) for high-risk smoldering myeloma. The MMRF supports access to safe and effective treatments for all patients and research to better define this population. #MultipleMyeloma #theMMRF

An @US_FDA ODAC will be held May 20th to discuss the potential approval for Dara in smoldering myeloma #mmsm Very good points made in the discussion 👇 ➡️ fda.gov/media/186527/d… Few important observations summarised here🧵

Link to study in @BloodJournal : ashpublications.org/blood/article/…

1/3🧵 🔥Hot off the press. ⭐️My co-authors & I are excited to share this just published paper @ASCO #ASCO25 #ASCOEdBook on a topic that is near & dear to my heart: ✅“The ART of #Oncology #Education & #Knowledge Sharing. It is All About the “#How” 👇🏻 ascopubs.org/doi/10.1200/ED…